Fundraising Fox

Catherine Boule

Investor

Managing Partner at Karista

Paris, France

Writes $600K – $6M checks · typically $3.3M

About

Catherine Boule, a molecular biologist with Institut Curie research and an MBA, combines scientific expertise with ~25 M&A/IPO exits and seed stakes in three of six French biotech NASDAQ companies.

Contact· self-published, not guessed

Invests in

BiotechCybersecurityDigital HealthHealthtechMedical DevicesSpace Tech

Experience

  1. KaristaManaging Partnercurrent2019 — presentFrance
  2. KaristaPartnercurrent2008 — presentParis, Île-de-France, France
  3. KaristaInvestment Director2003 — 2007
  4. IDFI IncubatorProject manager - Life Sciences2001 — 2003Paris, Île-de-France, France
  5. Institut CurieScientific Researcher2000 — 2001Paris, Île-de-France, France

Investments

Board seats

Deo.CareEchosensErytech PharmaIncepto MedicalNanobiotixTricares

Per the firm's website.

Colleagues at Karista

Agathe Biard
Chief Compliance Officer at Karista
Alain Gavin
Venture Partner at Karista
Amine Benmoussa
Partner at Karista
Anna Casal
Head of Communication at Karista
Baudouin Hue
Partner at Karista
Benjamin Zerbib
Investment Director at Karista
Emmanuel Daugeras
Investment Director at Karista
Michael Thomas
Investor at Karista

Network4

Baudouin Hue
Partner at Karista
Benjamin Zerbib
Investment Director at Karista
Emmanuel Daugeras
Investment Director at Karista
Michael Thomas
Investor at Karista

Investors connected to Catherine in public investor directories — a warm-intro map.

Frequently asked questions

Who is Catherine Boule?
Catherine Boule, a molecular biologist with Institut Curie research and an MBA, combines scientific expertise with ~25 M&A/IPO exits and seed stakes in three of six French biotech NASDAQ companies.
Where does Catherine Boule work?
Catherine Boule is Managing Partner at Karista.
What does Catherine Boule invest in?
Catherine Boule invests in Biotech, Cybersecurity, Digital Health, Healthtech, Medical Devices, Space Tech.
What check size does Catherine Boule write?
Catherine Boule typically writes checks of $600K – $6M.
What boards does Catherine Boule sit on?
Catherine Boule holds tracked board seats at Deo.Care, Echosens, Erytech Pharma, Incepto Medical, Nanobiotix, Tricares.
Where did Catherine Boule go to school?
Catherine Boule studied at AgroParisTech (MBA, Management); Université Paris Cité (Master 2 Recherche); Aix-Marseille University (Master 1, Sciences and oncology).

Same school

Also attended AgroParisTech13

Xavier MesnierPartner, Head of Frontiers in Health & Bio Investments at Verve VenturesAnne-Valérie BachManaging Director at CapagroPierre KienerInvestment Director at CapagroJuliette Raoul-FortésaInvestment Manager at CapagroTiphaine MuepuSenior Associate at CapagroMariliis HolmOperations & Scientific Diligence at Sustainable Food Ventures

+ 7 more

Also attended Université Paris Cité54

Michèle OllierInvestor at MedicxiMaija MuntilaTalent Lead at Lifeline VenturesZach WhiteInvestment Team at 8VCCyril CollonGeneral Partner at Partech VenturesIsabelle TressonCommunications & Marketing Lead at Partech VenturesElena BattistelloAnalyst at Novartis Venture Fund

+ 48 more

Also attended Aix-Marseille University23

Pierre SochaPartner at Amadeus Capital PartnersPhilippe DufourManaging Partner at Edenred VenturesNorbert FurnionManaging Partner at Edenred VenturesChristian SchattenmannInvestor at Bamboo Capital PartnersMyriam de TournemireSecretary General, Head of Impact at Eutopia VCLeen SegersVenture Partner at ScaleFund

+ 17 more

Shared employers

Also worked at Karista10

Olivier DubuissonManaging Partner at KaristaBaudouin HuePartner at KaristaYvan-Michel EhkirchManaging Partner at KaristaBenjamin ZerbibInvestment Director at KaristaTom BeauvironnetInvestment Manager at KaristaEmmanuel DaugerasInvestment Director at Karista

+ 4 more

Also worked at Institut Curie9

Elena BattistelloAnalyst at Novartis Venture FundVincent BrichardVenture Partner at EQT Life SciencesAlexandra GylfeFounding Partner at Nordic Science InvestmentsAlena IvashenkaLife Sciences Investor at Venture Capital World SummitLouise-Marie RakotoarisonAnalyst at Kurma PartnersClaire CatherinetSenior Associate, Crossover Strategy at Sofinnova Partners

+ 3 more